These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34017302)

  • 21. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow.
    Shi Y; Thrippleton MJ; Blair GW; Dickie DA; Marshall I; Hamilton I; Doubal FN; Chappell F; Wardlaw JM
    J Cereb Blood Flow Metab; 2020 Jan; 40(1):85-99. PubMed ID: 30295558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design.
    Brown R; Low A; Markus HS
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1271-1277. PubMed ID: 34344790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of white matter hyperintensities with networks of gray matter blood flow and volume in midlife adults: A coronary artery risk development in young adults magnetic resonance imaging substudy.
    Kim WSH; Luciw NJ; Atwi S; Shirzadi Z; Dolui S; Detre JA; Nasrallah IM; Swardfager W; Bryan RN; Launer LJ; MacIntosh BJ
    Hum Brain Mapp; 2022 Aug; 43(12):3680-3693. PubMed ID: 35429100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal Cerebral Blood Flow and Functional Connectivity Strength in Subjects With White Matter Hyperintensities.
    Huang H; Zhao K; Zhu W; Li H; Zhu W
    Front Neurol; 2021; 12():752762. PubMed ID: 34744987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.
    van der Veen PH; Muller M; Vincken KL; Hendrikse J; Mali WP; van der Graaf Y; Geerlings MI;
    Stroke; 2015 May; 46(5):1233-8. PubMed ID: 25804924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.
    Benedictus MR; Binnewijzend MAA; Kuijer JPA; Steenwijk MD; Versteeg A; Vrenken H; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Neurobiol Aging; 2014 Dec; 35(12):2665-2670. PubMed ID: 25018106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between White Matter Hyperintensities and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Wei CS; Yan CY; Yu XR; Wang L; Zhang R; Jiang JY; Dai Q; Li JR; Chen XM
    Front Med (Lausanne); 2022; 9():770184. PubMed ID: 35592851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic Progression of White Matter Hyperintensities in Alzheimer's Disease and Normal Aging: Results from the Sunnybrook Dementia Study.
    Ramirez J; McNeely AA; Berezuk C; Gao F; Black SE
    Front Aging Neurosci; 2016; 8():62. PubMed ID: 27047377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors.
    Stringer MS; Heye AK; Armitage PA; Chappell F; Valdés Hernández MDC; Makin SDJ; Sakka E; Thrippleton MJ; Wardlaw JM
    Neuroimage Clin; 2021; 32():102883. PubMed ID: 34911189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities.
    Marstrand JR; Garde E; Rostrup E; Ring P; Rosenbaum S; Mortensen EL; Larsson HB
    Stroke; 2002 Apr; 33(4):972-6. PubMed ID: 11935046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.
    Butt A; Kamtchum-Tatuene J; Khan K; Shuaib A; Jickling GC; Miyasaki JM; Smith EE; Camicioli R
    J Neurol Sci; 2021 Jul; 426():117481. PubMed ID: 33975191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better Correlation of Cognitive Function to White Matter Integrity than to Blood Supply in Subjects with Leukoaraiosis.
    Zhong G; Zhang R; Jiaerken Y; Yu X; Zhou Y; Liu C; Lin L; Tong L; Lou M
    Front Aging Neurosci; 2017; 9():185. PubMed ID: 28659787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.
    Phyu P; Merwick A; Davagnanam I; Bolsover F; Jichi F; Wheeler-Kingshott C; Golay X; Hughes D; Cipolotti L; Murphy E; Lachmann RH; Werring DJ
    Neurology; 2018 Apr; 90(16):e1379-e1385. PubMed ID: 29661900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter lesion burden in migraine with aura may be associated with reduced cerebral blood flow.
    Zhang Q; Datta R; Detre JA; Cucchiara B
    Cephalalgia; 2017 May; 37(6):517-524. PubMed ID: 27177583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    Uiterwijk R; Staals J; Huijts M; de Leeuw PW; Kroon AA; van Oostenbrugge RJ
    J Hypertens; 2017 Jun; 35(6):1263-1270. PubMed ID: 28169884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral small vessel disease and renal function: systematic review and meta-analysis.
    Makin SD; Cook FA; Dennis MS; Wardlaw JM
    Cerebrovasc Dis; 2015; 39(1):39-52. PubMed ID: 25547195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric symptoms as a sign of small vessel disease progression in cognitive impairment.
    Clancy U; Ramirez J; Chappell FM; Doubal FN; Wardlaw JM; Black SE
    Cereb Circ Cogn Behav; 2022; 3():100041. PubMed ID: 36324402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexities of cerebral small vessel disease, blood pressure, and dementia relationship: new insights from genetics.
    Sargurupremraj M; Soumare A; Bis JC; Surakka I; Jurgenson T; Joly P; Knol MJ; Wang R; Yang Q; Satizabal CL; Gudjonsson A; Mishra A; Bouteloup V; Phuah CL; van Duijn CM; Cruchaga C; Dufouil C; Chêne G; Lopez O; Psaty BM; Tzourio C; Amouyel P; Adams HH; Jacqmin-Gadda H; Ikram MA; Gudnason V; Milani L; Winsvold BS; Hveem K; Matthews PM; Longstreth WT; Seshadri S; Launer LJ; Debette S
    medRxiv; 2023 Aug; ():. PubMed ID: 37790435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.